Table of Contents
Fetching ...

Heart Failure's First Shock and Nurse-Led Chronic Care

Moslem Rashidi, Luke B. Connelly, Gianluca Fiorentini

Abstract

We study how a first heart-failure hospitalization, an adverse health shock, changes patients' care, and whether a nurse-led chronic-care program sustains those post-shock investments. Using linked population-wide administrative records from Italy's Romagna Local Health Authority (2017-2023), we anchor event time at each patient's first CHF admission and exploit staggered timing to estimate dynamic effects. The shock triggers a sharp post-discharge surge: beta-blocker adherence, cardiology follow-up, and echocardiography rise immediately, while emergency-room use spikes just before admission and then stabilizes. We then estimate the incremental impact of enrollment in the Nurse-led Program for Chronic Patients (NPCP) using the interaction-weighted event-study estimator for staggered adoption. Under conventional difference-in-differences inference, NPCP strengthens long-run preventive engagement, with little detectable change in emergency-room use. HonestDiD sensitivity analysis indicates these gains are economically meaningful but not statistically definitive under modest departures from parallel trends.

Heart Failure's First Shock and Nurse-Led Chronic Care

Abstract

We study how a first heart-failure hospitalization, an adverse health shock, changes patients' care, and whether a nurse-led chronic-care program sustains those post-shock investments. Using linked population-wide administrative records from Italy's Romagna Local Health Authority (2017-2023), we anchor event time at each patient's first CHF admission and exploit staggered timing to estimate dynamic effects. The shock triggers a sharp post-discharge surge: beta-blocker adherence, cardiology follow-up, and echocardiography rise immediately, while emergency-room use spikes just before admission and then stabilizes. We then estimate the incremental impact of enrollment in the Nurse-led Program for Chronic Patients (NPCP) using the interaction-weighted event-study estimator for staggered adoption. Under conventional difference-in-differences inference, NPCP strengthens long-run preventive engagement, with little detectable change in emergency-room use. HonestDiD sensitivity analysis indicates these gains are economically meaningful but not statistically definitive under modest departures from parallel trends.
Paper Structure (14 sections, 1 theorem, 11 equations, 30 figures, 7 tables)

This paper contains 14 sections, 1 theorem, 11 equations, 30 figures, 7 tables.

Key Result

Lemma 1

If $R_{it}$ is a deterministic function of $(T_i^H,T_i^E)$ and conditional parallel trends hold on the kept support, then the Sun and Abraham (2021) interaction-weighted event-study estimand remains identified on $\{R_{it}=1\}$.

Figures (30)

  • Figure 1: Moving-average event-time trajectories around the first CHF hospitalization ($t=0$) for panels (a)--(d): $\beta$-blocker adherence, cardiologist visits, echocardiograms, and ER visits. Shaded bands show 95% CIs over $\pm 12$ quarters.
  • Figure 2: NPCP effects from the Sun--Abraham (2021) event study. Event time is in quarters around the first CHF hospitalization ($\tau=0$; reference = $-2$). Panels report $\beta$-blocker adherence, cardiology visits, echocardiograms, and ER visits. Points are estimates; bars are 95% CIs; the long-run bin pools $\tau \ge 6$.
  • Figure 3: HonestDiD sensitivity analysis (Rambachan and Roth, 2023) for the Sun--Abraham estimates. The figure reports 95% confidence intervals across $M \in \{0,0.5,1,1.5,2\}$, where larger $M$ permits larger departures from parallel trends.
  • Figure B1: New enrollments into the nurse-led program by district and quarter, 2017–2023. Each panel plots intake_dt, the number of patients who newly enroll in the current quarter (enroll_q = quarter_period). The variable is constructed from the CHF patient–quarter panel and aggregated to the district–quarter level.
  • Figure C1: Moving-average event-time trajectories around the first CHF hospitalization ($t=0$) for panels (a)--(d): $\beta$-blocker adherence, cardiologist visits, echocardiograms, and ER visits. Lines plot forward and backward moving averages anchored at $t=0$ and $t=-1$; shaded bands report 95% confidence intervals for treated and control groups over $\pm 12$ quarters. The sample includes treated and untreated patients and excludes the 121 patients who enrolled in NPCP before the index hospitalization.
  • ...and 25 more figures

Theorems & Definitions (2)

  • Lemma 1
  • proof